Terms and Conditions of Use

Covered insulins:

  • NovoLog® (insulin aspart injection) 100 U/mL
  • NovoLog® Mix 70/30 (insulin aspart protamine and insulin aspart injectable suspension) 100 U/mL
  • Levemir® (insulin detemir injection) 100 U/mL
  • Tresiba® (insulin degludec injection) 100 U/mL, 200 U/mL
  • Fiasp® (insulin aspart injection) 100 U/mL
  • Novolin® N vial (isophane insulin human suspension) 100 U/mL
  • Novolin® R vial (insulin human injection) 100 U/mL
  • Novolin® 70/30 vial (70% human insulin isophane suspension and 30% human insulin injection) 100 U/mL
  • Novolin® 70/30 FlexPen® 100 U/mL    
  • Insulin Aspart Injection 100 U/mLa
  • Insulin Aspart Protamine and Insulin Aspart Injectable Suspension 100 U/mLa

Terms and conditions:

  • In order to redeem this card, patient must have a valid prescription for a covered insulin. A valid Prescriber ID# is required on the prescription. Patient is not eligible where prohibited by law. This offer may not be redeemed for cash. By using this offer, you are certifying that you meet the eligibility criteria and will comply with the terms and conditions described herein and will not seek reimbursement for any benefit received through this savings offer. Medicare Part D beneficiaries must agree to obtain their Covered Insulins subject to this offer throughout the entire applicable Part D coverage year, if Part D coverage would otherwise be available. By enrolling for this card and utilizing the offer, Medicare Part D beneficiaries acknowledge and agree that Novo Nordisk may use information provided to Novo Nordisk or its partners to report information about offer enrollment to Part D plans. Medicare Part D beneficiaries further acknowledge and agree that any amounts paid in connection with this offer do not count towards TrOOP. Once enrolled in the program, the Savings Offer is valid for the calendar year. Novo Nordisk’s Eligibility and Restrictions, and Offer Details may change from time to time without prior notice. For latest Terms and Conditions, please visit www.NovoCare.com/99.
  • This offer is valid in the United States, may be redeemed at participating retail pharmacies, and is intended for outpatient use only. Availability of the offer in Massachusetts will be dependent upon state law in effect at the time patient presents the offer when paying for the covered medications. Void where taxed, restricted, or prohibited by law. This offer is not transferable and is limited to one offer per person. Not valid if reproduced.
  • This savings offer cannot be combined with any coupon, certificate, voucher, or similar offer.
  • By activating this offer, patient represents and warrants that he or she has not submitted, and will not submit, a claim for reimbursement to any payer or prescription insurance plan, including any government program, for this prescription. Patient is responsible for complying with any insurance carrier disclosure requirements, including disclosing any savings received from this program. It is illegal to (or offer to) sell, purchase, or trade this offer.
  • This program is managed by ConnectiveRx on behalf of Novo Nordisk. The parties reserve the right to rescind, revoke, or amend this offer without notice at any time. Patients with questions may call 1-888-910-0632.


When you apply this offer, you are certifying that you have not submitted a claim for reimbursement to any payer or prescription insurance plan, including any government program, for this prescription, or where prohibited by law. Participation in this program must comply with all applicable laws and regulations as a pharmacy provider. By participating in this program, you are certifying that you will comply with the eligibility criteria, and terms and conditions described herein. You also certify that you will not seek reimbursement for any benefit received through this offer or apply the benefit received to the True Out-of-Pocket (TrOOP).

Pharmacist instructions:

Patient is not eligible if he/she seeks reimbursement from any payer or prescription insurance plan.

Submit each claim to SS&C Health using BIN 019158. A valid Other Coverage Code (e.g. 0 or 1) is required.  The patient is responsible for the first $99 per 35 mL of any combination of covered insulins and reimbursement will be received from SS&C Health.

Patient will pay $99 per 35 mL (i.e., up to 3 vials or 2 packs of pens or any combination thereof) up to a maximum of 150 mL per calendar month. Once enrolled in the program, the Savings Offer is valid for the calendar year.

For any questions regarding SS&C Health online processing, please call the Pharmacy Help Desk at 1-844-373-0987.

Terms and Conditions for SMS/Texting Program

Please read these terms and conditions carefully. By texting “AGREE” back, you affirm that you are a US resident, 18 years of age or older, and expressly consent to receive non-marketing and marketing text messages from Novo Nordisk or its partners in connection with Novo Nordisk’s My$99Insulin Card SMS Program (the “PROGRAM”). Your consent to receive marketing messages is not required for the receipt of goods or services from Novo Nordisk.

By participating in these SMS text messaging programs, you also agree to be bound by the PROGRAM’s Full Mobile Terms of Use & Conditions and the Novo Nordisk Privacy Statement. For more information about data use and collection, please read the most recent version of Novo Nordisk’s Privacy Statement.

The PROGRAM’s Full Mobile Terms and Conditions of Use:

Express Consent. As stated above, by texting “AGREE” back, I affirm that I am a US resident, am 18 years of age or older, and expressly consent to receive non-marketing and marketing text messages (SMS) and texts with images (MMS) from Novo Nordisk or its partners in connection with the PROGRAM. I understand that these messages may be made with an auto-dialer to my telephone number and that my consent to receive marketing text messages is not required for the receipt of goods or services from Novo Nordisk. These messages may be sent from any of these phone numbers:

Shortcode: 24177

Message Frequency:

The PROGRAM’s message frequency will vary. Please be aware that Novo Nordisk brands and services may have separate text messaging programs. The total number of text messages you receive from Novo Nordisk or its partners, therefore, may vary based on the number of Novo Nordisk text messaging programs for which you sign-up to receive messages.


You will not be charged any fee from Novo Nordisk or its partners in connection with the PROGRAM to receive non-marketing or marketing text messages. However, Novo Nordisk encourages you to check with your mobile service provider to see what other message and data rates may apply, including any applicable roaming charges.

Supported Carriers. The following US carriers are supported:

Major Carriers: AT&T, Verizon Wireless, Sprint, T-Mobile, MetroPCS, U.S. Cellular, Alltel, Boost Mobile, Nextel, and Virgin Mobile.

Minor Carriers: Alaska Communications Systems (ACS), Appalachian Wireless (EKN), Bluegrass Cellular, Cellular One of East Central IL (ECIT), Cellular One of Northeast Pennsylvania, Cincinnati Bell Wireless, Cricket, Coral Wireless (Mobi PCS), COX, Cross, Element Mobile (Flat Wireless), Epic Touch (Elkhart Telephone), GCI, Golden State, Hawkeye (Chat Mobility), Hawkeye (NW Missouri), Illinois Valley Cellular, Inland Cellular, iWireless (Iowa Wireless), Keystone Wireless (Immix Wireless/PC Man), Mosaic (Consolidated or CTC Telecom), Nex-Tech Wireless, NTelos, Panhandle Communications, Pioneer, Plateau (Texas RSA 3 Ltd), Revol, RINA, Simmetry (TMP Corporation), Thumb Cellular, Union Wireless, United Wireless, Viaero Wireless, and West Central (WCC or 5 Star Wireless).    

Text Opt-Out:

Please know you may always opt out of receiving text messages from Novo Nordisk or its partners related to the PROGRAM at any time by sending a reply text stating “STOP,” texting “STOP” to 24177 or visiting www.NovoCare.com/Opt99.

However, please know that you will remain opted into other Novo Nordisk text and email messaging programs for which you have enrolled, if enrolled.

Website Opt-Out:

In addition to opting-out of the PROGRAM as set forth above, you may also choose to stop receiving all text messages related to the PROGRAM by visiting www.NovoCare.com/Opt99 and entering your cell phone number into the field provided there.  Please note that by opting out via the website, you will no longer receive any text messages from the PROGRAM. You will remain opted into other Novo Nordisk text or other email messaging programs for which you have enrolled.

Your Mobile Telephone Number. You represent that you are the account holder for the mobile telephone number you opt in to receive text messages for the PROGRAM.


To receive text messages or calls for the PROGRAM, you must be a resident of the US and 18 years of age or older. Novo Nordisk reserves the right to require you to prove that you are at least 18 years of age.

Access or Delivery to Mobile Network Is Not Guaranteed. Delivery of information and content to a mobile device is not guaranteed and may fail due to a variety of circumstances or conditions. Alerts sent via text message may not be delivered if the mobile phone is not in range of a transmission site or if sufficient network capacity is not available at a particular time. Even within a coverage area, factors beyond the control of the wireless carrier may interfere with message delivery, including the customer’s equipment, terrain, proximity to buildings, foliage, and weather. Novo Nordisk will not be held responsible for any delays in the receipt of any text messages as delivery is subject to effective transmission from your mobile service provider or network operator. You understand and acknowledge that network services, including but not limited to mobile network services, are outside of Novo Nordisk’s control, and Novo Nordisk is not responsible or liable for issues arising from them.

Privacy & Security:

Since Novo Nordisk appreciates the value of your private personal health information, Novo Nordisk wants you to understand that it cannot guarantee the security of any personal health information transmitted via SMS text message. SMS text messages are not encrypted or protected. These communications, and possibly the content, may be stored on servers where mobile carrier employees, governments, or other unknown third parties might be able to view or access them.

Novo Nordisk understands and values the importance of your privacy. Please be aware that the data obtained from you in connection with this SMS message service may, among other things, include your cell phone number, carrier name, and message date, time, and content. We may use this information to contact you and to provide the services you request from us. In addition, your responses to any survey questions in this program will be combined with the responses from other participants in this program and shared with Novo Nordisk and its PROGRAM partners. However, the information shared with Novo Nordisk and its PROGRAM partners will not include your name, date of birth, cell phone number, or cell phone carrier. For more information on how we collect and use your information, please read our full Privacy Statement. If you opt out (as explained above) from receiving PROGRAM text messages, any future data collection from you will end. You also understand that a significant portion of the PROGRAM is conducted via text messaging. These text messages may contain health information. Standard text messaging is not encrypted, and a third party could read these messages.

PROGRAM Terms of Use:

This program does not substitute medical advice from your health care provider. You will have to contact him or her directly about issues, questions, or concerns. (See NOT MEDICAL ADVICE below.) You further understand that this program is not a means to communicate product issues or negative side effects to Novo Nordisk. You are encouraged to report negative side effects of prescription drugs to the FDA at www.fda.gov/medwatch or by phone at 1-800-FDA-1088. Novo Nordisk is not responsible for monitoring or recording text messages that may constitute an issue or negative side effect. However, if you are using a Novo Nordisk product as treatment and some of your entered responses can be interpreted as a side effect of the medication, Novo Nordisk reserves the right to contact you for more information by phone or written communication. For additional information about your medication, please call Novo Nordisk Customer Care at 1-833-693-6742.    

Not Medical Advice:


Changes to Terms and Conditions of Use:

Novo Nordisk may revise, modify, or amend the PROGRAM’s Mobile Terms and Conditions of Use for text messages and calls at any time. Any such revision, modification, or amendment will take effect when such changes are circulated to PROGRAM participants via text message. Novo Nordisk encourages review to thoroughly review any changes to Terms of Use and Conditions should you receive them.

Termination of Text Messaging:

Novo Nordisk may suspend or terminate your receipt of Novo Nordisk text messages if Novo Nordisk believes you are in breach of these Mobile Terms and Conditions for SMS Messages. Your receipt of Novo Nordisk text messages is also subject to termination in the event that your mobile telephone service terminates or lapses. Novo Nordisk reserves the right to modify or discontinue, temporarily or permanently, all or any part of Novo Nordisk text messages, with or without notice. You assume sole responsibility for the proper use and scheduling of any medications, treatments, and procedures related to the patient’s health care and disease management. Novo Nordisk assumes no responsibility for the accuracy or appropriateness of any information entered by you.    

aUnbranded biologic from Novo Nordisk Pharma, Inc. (NNPI)

Novo Nordisk logo

NovoCare® is a registered trademark of Novo Nordisk A/S.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
All other trademarks, registered or unregistered, are the property of their respective owners.

© 2021 Novo Nordisk  All rights reserved. US20NC00085  January 2021